Genetic Analysis of Fraser Syndrome and Fryns Syndrome
Molecular Genetic Analysis of Fraser Syndrome and Fryns Syndrome
2 other identifiers
observational
400
1 country
1
Brief Summary
This study will examine blood or other tissue samples from patients with Fraser syndrome and patients with Fryns syndrome to try to identify the gene responsible for these diseases. Fraser syndrome is characterized by congenital abnormalities including cryptophthalmos (lack of eyelid formation), syndactyly (webbed fingers or toes) and abnormal genitalia. Patients may also have abnormalities of the nose, ears and larynx (voice box), cleft lip or palate, and kidney agenesis. Fryns syndrome is characterized by hernia through the diaphragm, cloudy cornea, coarse facial features, cleft lip or palate, abnormal fingers and toes, heart, kidney and brain malformations and hydrocephalus (accumulation of fluid around the brain). This protocol consists of laboratory study only; it does not involve patient care or patient counseling. Patients with Fraser syndrome or Fryns syndrome are eligible for this study. Parents and healthy siblings of patients will also be included for genetic study, and parents of children with undiagnosed multiple congenital anomalies syndromes will be included for comparison study. Participants will provide a blood sample (about 8 to 10 teaspoons from adults; 1 to 3 teaspoons from children) or sample of skin cells collected by swabbing the inner surface of the cheek. Some patients may undergo a skin biopsy, in which a small skin sample (about 1/8-inch in diameter) is surgically removed. The tissue samples will be used to obtain DNA (genetic material) for laboratory testing. A permanent cell line-a collection of cells grown in the laboratory from the original tissue specimen-will also be established to enable additional testing in the future.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Apr 2002
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
April 1, 2002
CompletedFirst Submitted
Initial submission to the registry
April 4, 2002
CompletedFirst Posted
Study publicly available on registry
April 5, 2002
CompletedStudy Completion
Last participant's last visit for all outcomes
February 1, 2003
CompletedMarch 4, 2008
February 1, 2003
April 4, 2002
March 3, 2008
Conditions
Keywords
Eligibility Criteria
You may qualify if:
- Satisfying diagnostic criteria for Fraser syndrome. These are at least two major criteria and one minor criterion (listed below) or one major criterion and four minor criteria.
- Major criteria:
- Cryptophthalmos
- Syndactyly
- Abnormal genitalia
- Sib with cryptophthalmos syndrome
- Minor criteria:
- Congenital malformation of the nose
- Congenital malformations of the ears
- Congenital malformation of the larynx
- Cleft lip and/or palate
- Skeletal defects
- Umbilical hernia
- Renal agenesis
- Mental retardation
- +4 more criteria
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
National Human Genome Research Institute (NHGRI)
Bethesda, Maryland, 20892, United States
Related Publications (3)
Acosta JM, Chai Y, Meara JG, Bringas P Jr, Anderson KD, Warburton D. Prenatal exposure to nitrofen induces Fryns phenotype in mice. Ann Plast Surg. 2001 Jun;46(6):635-40. doi: 10.1097/00000637-200106000-00012.
PMID: 11405365BACKGROUNDAndiran F, Tanyel FC, Hicsonmez A. Fraser syndrome associated with anterior urethral atresia. Am J Med Genet. 1999 Feb 12;82(4):359-61. doi: 10.1002/(sici)1096-8628(19990212)82:43.0.co;2-q. No abstract available.
PMID: 10051174BACKGROUNDBalci S, Altinok G, Ozaltin F, Aktas D, Niron EA, Onol B. Laryngeal atresia presenting as fetal ascites, olygohydramnios and lung appearance mimicking cystic adenomatoid malformation in a 25-week-old fetus with Fraser syndrome. Prenat Diagn. 1999 Sep;19(9):856-58. doi: 10.1002/(sici)1097-0223(199909)19:93.0.co;2-x.
PMID: 10521845BACKGROUND
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Sponsor Type
- NIH
Study Record Dates
First Submitted
April 4, 2002
First Posted
April 5, 2002
Study Start
April 1, 2002
Study Completion
February 1, 2003
Last Updated
March 4, 2008
Record last verified: 2003-02